Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (2014 - 2022)

Scinai Immunotherapeutics has disclosed Interest Coverage Ratio across 9 years of filings, most recently posting 0.85 for Q3 2022.

• Interest Coverage Ratio for Q3 2022 came in at 0.85, down 71.2% year-over-year; the trailing twelve-month figure through Jun 2023 was 4.37 (down 694.12% YoY), and the FY2021 annual result was 1.0, up 313.09% from the prior year.
• Interest Coverage Ratio came in at 0.85 for Q3 2022 at Scinai Immunotherapeutics, up from 0.9 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 135.47 in Q1 2020 to a low of 193.07 in Q3 2020.
• The 5-year median for Interest Coverage Ratio is 2.91 (2021), against an average of 2.2.
• Peak annual rise in Interest Coverage Ratio reached 3724.82% in 2020, while the deepest fall reached 713.18% in 2020.
• Scinai Immunotherapeutics' Interest Coverage Ratio stood at 3.65 in 2018, then surged by 762.11% to 31.49 in 2019, then plunged by 50.15% to 15.7 in 2020, then sank by 130.47% to 4.78 in 2021, then jumped by 117.68% to 0.85 in 2022.
• The last three Interest Coverage Ratio figures came in at 0.85 (Q3 2022), 0.9 (Q2 2022), and 3.55 (Q1 2022), per Business Quant data.